Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 221493
Licensor jointly and collectively developed certain inventions regarding d-Methadone in the context of psychiatric use (the â€œExisting Inventionâ€).
Licensor jointly and collectively developed certain further inventions regarding d-Methadone in the context of neurological and other uses (the â€œNew Inventionâ€).
This agreement is in regards to d-Methadone in the context of analgesic use, psychiatric use, neurological and other uses.
Licensed IP shall mean Licensorâ€™s right, title, and interest in and to (a) the Licensed Inventions (including, without limitation, all existing work relating to the Licensed Inventions) and (b) any and all Future Inventions.
Related Licensed IP shall mean all of Licensorâ€™s intellectual property related to the Licensed IP. For the avoidance of doubt, the Licensed IP and the Related Licensed IP collectively include, but are not limited to, Licensorâ€™s right, title and interest in and to the Patent Rights, Technology, and Licensed Intangible Assets.
Licensed Product shall mean any service, composition, or product (a) that uses Technology; or (b) that is claimed in Patent Rights; or (c) that is produced or enabled by a Licensed Method; or (d) the manufacture, use, sale, offer for sale, or importation of which would constitute, but for the license granted to Licensee under this Agreement, an infringement, an inducement to infringe or contributory infringement, of any pending or issued claim within the Patent Rights.
Patent shall mean any and all patents, pending patents, patent applications (whether registered or unregistered) (and equivalents of any of the foregoing including certificates of invention, and any and all divisions, continuations, provisional applications, continuations-in-part, continued prosecution applications, requests for continued examinations, additions, renewals, extension, re-examinations, reissues, supplementary protection certificates, and all United States and foreign counterparts of any the foregoing.
Patent Rights shall mean all of Licensorâ€™s right, title, and interest in and to the Patents set forth (which may be updated from time to time to reflect new Patents including without limitation from Future Inventions) and any other Patent related to any of the Licensed IP and/or the Related Licensed IP, including its development manufacture, packaging, use, marketing, promotion, distribution, licensing, offer for sale, or importation. For the avoidance of doubt, the Patent Rights shall include any Patent relating to any of the Licensed IP and/or the Related Licensed IP licensed to Licensee herein, including, without limitation, Patents relating to any and all of Licensorâ€™s right, title and interest in and to Future Inventions (including the development manufacture, packaging, use, marketing, promotion, distribution, licensing, offer for sale, or importation of any of the Licensed IP and/or the Related Licensed IP), filed, requested, and/or issued after the Effective Date regardless of whether the information updated to reflect such Patent.
Technology shall mean all right, title, and interest of Licensor in and to the Technical Information related to any of the Licensed Products, Licensed Inventions, Licensed IP, and/or the Related Licensed IP, including any of their development, manufacture, packaging, use, marketing, promotion, distribution, licensing, offer for sale, or importation.
d-methadone (dextromethadone), is a novel, N-methyl-D-aspartate (NMDA) receptor antagonist being developed for the treatment of depression and neuropathic pain, and/or other potential indications. As a single isomer of racemic methadone, d-Methadone has been shown to possess NMDA antagonist properties with virtually no opioid activity or ketamine-like toxicities at the expected therapeutic doses. The activation of NMDA receptors has been associated with depression and neuropathic pain and it is expected that d-Methadone will have a therapeutic role by blocking this activity. In contrast, racemic methadone is a long-acting narcotic producing typical opioid side effects used in the treatment of various pain states and as a substitution therapy in opioid addiction.
A relative of methadone, a widely known synthetic opioid medication, d-Methadone represents half of methadoneâ€™s chemical structure with profoundly different activity on the mu opioid receptor, considered a â€œgateway for addiction.â€ Methadone is an opioid used for opioid maintenance therapy in opioid dependence, and for pain.
IPSCIO Record ID: 27356
IPSCIO Record ID: 25850
IPSCIO Record ID: 203524
The New Compound shall mean a chemical entity (including salts and solvates thereof, which shall be considered the same New Compound for purposes of this Agreement) covered by any valid and unexpired claim of Licensed Patents, but shall exclude in all cases the Roberts Agreement Compound.
The New Product means a finished, formulated pharmaceutical product containing a New Compound, together with all improvements and line extensions thereon which may be included in any supplement, modification or addition to the relevant Regulatory Approval to the extent that any such improvements or line extensions contain a New Compound.
Licensee is developing alvimopan, a peripherally selective mu opioid antagonist for management of postoperative ileus, opioid induced bowel dysfunction and certain other indications. Alvimopan is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the constipation effects of opioid (narcotic) medications that are used to treat pain after surgery.